SG182322A1 - Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies - Google Patents

Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies Download PDF

Info

Publication number
SG182322A1
SG182322A1 SG2012049003A SG2012049003A SG182322A1 SG 182322 A1 SG182322 A1 SG 182322A1 SG 2012049003 A SG2012049003 A SG 2012049003A SG 2012049003 A SG2012049003 A SG 2012049003A SG 182322 A1 SG182322 A1 SG 182322A1
Authority
SG
Singapore
Prior art keywords
seq
base pairs
dna
dmrs
sample
Prior art date
Application number
SG2012049003A
Other languages
English (en)
Inventor
Philippos C Patsalis
Elisavet A Papageorgiou
Original Assignee
Nipd Genetics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nipd Genetics Ltd filed Critical Nipd Genetics Ltd
Publication of SG182322A1 publication Critical patent/SG182322A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG2012049003A 2010-01-26 2011-01-26 Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies SG182322A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29833910P 2010-01-26 2010-01-26
US40542110P 2010-10-21 2010-10-21
PCT/IB2011/000217 WO2011092592A2 (en) 2010-01-26 2011-01-26 Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies

Publications (1)

Publication Number Publication Date
SG182322A1 true SG182322A1 (en) 2012-08-30

Family

ID=44278821

Family Applications (1)

Application Number Title Priority Date Filing Date
SG2012049003A SG182322A1 (en) 2010-01-26 2011-01-26 Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies

Country Status (17)

Country Link
US (1) US9249462B2 (cg-RX-API-DMAC7.html)
EP (1) EP2529032B1 (cg-RX-API-DMAC7.html)
JP (1) JP2013517789A (cg-RX-API-DMAC7.html)
KR (1) KR20120107512A (cg-RX-API-DMAC7.html)
CN (1) CN102892899A (cg-RX-API-DMAC7.html)
AU (1) AU2011210255B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012018458A2 (cg-RX-API-DMAC7.html)
CA (1) CA2786174A1 (cg-RX-API-DMAC7.html)
CY (1) CY1118864T1 (cg-RX-API-DMAC7.html)
DK (1) DK2529032T3 (cg-RX-API-DMAC7.html)
EA (1) EA023565B1 (cg-RX-API-DMAC7.html)
ES (1) ES2623156T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ601079A (cg-RX-API-DMAC7.html)
PL (1) PL2529032T3 (cg-RX-API-DMAC7.html)
PT (1) PT2529032T (cg-RX-API-DMAC7.html)
SG (1) SG182322A1 (cg-RX-API-DMAC7.html)
WO (1) WO2011092592A2 (cg-RX-API-DMAC7.html)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101153336B (zh) 2006-09-27 2011-09-07 香港中文大学 检测dna甲基化程度的方法和试剂盒
US8962247B2 (en) 2008-09-16 2015-02-24 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
US8476013B2 (en) 2008-09-16 2013-07-02 Sequenom, Inc. Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
DK2516680T3 (en) 2009-12-22 2016-05-02 Sequenom Inc Method and kits to identify aneuploidy
EP4155401A1 (en) 2012-03-02 2023-03-29 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10504613B2 (en) 2012-12-20 2019-12-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
US20140093873A1 (en) 2012-07-13 2014-04-03 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
US10706957B2 (en) 2012-09-20 2020-07-07 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
HUE053822T2 (hu) 2012-09-20 2021-07-28 Univ Hong Kong Chinese Nem invazív módszer daganat metilom meghatározása plazmából
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
WO2014051522A1 (en) * 2012-09-26 2014-04-03 Agency For Science, Technology And Research Biomarkers for down syndrome prenatal diagnosis
EP3597774A1 (en) 2013-03-13 2020-01-22 Sequenom, Inc. Primers for dna methylation analysis
KR20140118682A (ko) 2013-03-29 2014-10-08 (주)셀트리온 2 이상의 인플루엔자 a 바이러스 중화 결합 분자를 포함하는 조성물
WO2015138774A1 (en) * 2014-03-13 2015-09-17 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
RU2583830C2 (ru) * 2014-04-21 2016-05-10 Закрытое акционерное общество "Геноаналитика" Способ неинвазивной пренатальной диагностики анеуплоидий плода
US10801067B2 (en) * 2014-05-09 2020-10-13 Eurofins Lifecodexx Gmbh Detection of DNA that originates from a specific cell-type and related methods
EP2942400A1 (en) 2014-05-09 2015-11-11 Lifecodexx AG Multiplex detection of DNA that originates from a specific cell-type
EP2942401A1 (en) 2014-05-09 2015-11-11 Lifecodexx AG Detection of DNA that originates from a specific cell-type
US20180187267A1 (en) * 2017-01-05 2018-07-05 Michael J. Powell Method for conducting early detection of colon cancer and/or of colon cancer precursor cells and for monitoring colon cancer recurrence
US10174383B2 (en) * 2014-08-13 2019-01-08 Vanadis Diagnostics Method of estimating the amount of a methylated locus in a sample
WO2016176846A1 (zh) * 2015-05-06 2016-11-10 安诺优达基因科技(北京)有限公司 检测染色体非整倍性的试剂盒、装置和方法
ES2790533T3 (es) 2015-05-22 2020-10-28 Nipd Genetics Public Company Ltd Análisis paralelo múltiplex de regiones genómicas blanco para análisis prenatales no invasivos
HUE050491T2 (hu) 2015-11-10 2020-12-28 Eurofins Lifecodexx Gmbh Magzati kromoszomális aneuploidiák kimutatása olyan DNS régiókat alkalmazva, amelyek különbözõképpen vannak metilezve a magzat és a terhes nõstény között
SG11201804651XA (en) * 2015-12-04 2018-07-30 Green Cross Genome Corp Method for determining copy-number variation in sample comprising mixture of nucleic acids
KR101817180B1 (ko) * 2016-01-20 2018-01-10 이원다이애그노믹스(주) 염색체 이상 판단 방법
US11078475B2 (en) 2016-05-03 2021-08-03 Sinai Health System Methods of capturing cell-free methylated DNA and uses of same
CN115161390B (zh) 2016-05-30 2025-12-05 香港中文大学 使用血液中的无细胞dna检测血液病症
CN109112209B (zh) * 2017-06-25 2022-06-24 国家卫生计生委科学技术研究所 用于无创产前检测胎儿非整倍体染色体的参考品
CN111989407B (zh) 2018-03-13 2024-10-29 格里尔公司 异常的片段检测及分类
KR20200060969A (ko) 2018-11-23 2020-06-02 (주)셀트리온 인플루엔자 바이러스 질환을 치료하기 위한 투여 요법
EP3899953A1 (en) 2018-12-21 2021-10-27 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free-dna samples
US20230151409A1 (en) * 2020-03-30 2023-05-18 Vilnius University Methods and compositions for noninvasive prenatal diagnosis through targeted covalent labeling of genomic sites
US12592321B2 (en) 2020-06-19 2026-03-31 University Health Network Cancer detection and classification using methylome analysis
KR102332540B1 (ko) * 2020-07-02 2021-11-29 의료법인 성광의료재단 다운증후군 특이적인 후성학적 마커를 이용한 다운증후군 진단 방법
US20250079015A1 (en) * 2022-01-10 2025-03-06 Washington State University Dna methylation biomarkers for preterm birth
JP2026515793A (ja) * 2023-04-14 2026-05-19 アデラ・インコーポレーテッド セルフリー核酸をプロセシングするための方法およびシステム
CN117385023A (zh) * 2023-10-27 2024-01-12 中国科学院苏州生物医学工程技术研究所 一种用于21-三体产前筛查的生物标志物、筛选方法及其应用
WO2025179073A1 (en) * 2024-02-21 2025-08-28 Adela, Inc. Methods and systems for tissue informed differentially methylated region analysis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
DE602004018009D1 (de) 2003-09-22 2009-01-08 Trisogen Biotechnology Ltd Par Zum nachweis einer änderung einer locus-kopienzahl geeignete verfahren
US20050282213A1 (en) * 2003-09-22 2005-12-22 Trisogen Biotechnology Limited Partnership Methods and kits useful for detecting an alteration in a locus copy number
GB0413688D0 (en) 2004-06-18 2004-07-21 Novartis Forschungsstiftung Analysis of methylated nucleic acid
EP1817430B1 (en) 2004-11-29 2009-09-16 Klinikum der Universität Regensburg Means and methods for detecting methylated dna
US20090042195A1 (en) * 2005-10-07 2009-02-12 Bradford Coffee Methods and systems for screening for and diagnosing dna methylation associated abnormalities and sex chromosome aneuploidies
US7901884B2 (en) 2006-05-03 2011-03-08 The Chinese University Of Hong Kong Markers for prenatal diagnosis and monitoring
US12054776B2 (en) 2007-07-23 2024-08-06 The Chinese University Of Hong Kong Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing
JP5322471B2 (ja) 2008-03-27 2013-10-23 シスメックス株式会社 メチル化dnaの解析方法及びプライマーセット
US8476013B2 (en) 2008-09-16 2013-07-02 Sequenom, Inc. Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses

Also Published As

Publication number Publication date
ES2623156T3 (es) 2017-07-10
PL2529032T3 (pl) 2017-07-31
AU2011210255B2 (en) 2014-11-20
EP2529032B1 (en) 2017-01-25
EP2529032A2 (en) 2012-12-05
NZ601079A (en) 2014-08-29
JP2013517789A (ja) 2013-05-20
DK2529032T3 (en) 2017-05-01
WO2011092592A2 (en) 2011-08-04
WO2011092592A3 (en) 2011-11-03
CA2786174A1 (en) 2011-08-04
BR112012018458A2 (pt) 2018-07-10
CY1118864T1 (el) 2018-01-10
KR20120107512A (ko) 2012-10-02
EA201290716A1 (ru) 2013-06-28
US9249462B2 (en) 2016-02-02
US20120282613A1 (en) 2012-11-08
CN102892899A (zh) 2013-01-23
PT2529032T (pt) 2017-05-04
EA023565B1 (ru) 2016-06-30
AU2011210255A1 (en) 2012-07-26

Similar Documents

Publication Publication Date Title
US9249462B2 (en) Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies
US11697846B2 (en) Detecting and classifying copy number variation
AU2015360298B2 (en) Using cell-free DNA fragment size to determine copy number variations
Chan et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis
US10169530B2 (en) Gene fusions and alternatively spliced junctions associated with breast cancer
ES2930180T3 (es) Métodos para enriquecer ácido nucleico canceroso a partir de una muestra biológica
Avent et al. Cell-free fetal DNA in the maternal serum and plasma: current and evolving applications
EP3500966B1 (en) Immunotherapy markers and uses therefor
AU2016391100A1 (en) Using cell-free DNA fragment size to determine copy number variations
Hyland et al. Non-invasive fetal RHD genotyping for RhD negative women stratified into RHD gene deletion or variant groups: comparative accuracy using two blood collection tube types
Sillence et al. Rapid RHD zygosity determination using digital PCR
CA3236814A1 (en) Systems and methods for gene expression and tissue of origin inference from cell-free dna
Pan et al. The fragmentation patterns of maternal plasma cell‐free DNA and its applications in non‐invasive prenatal testing
Tynan et al. Multiplexed analysis of circulating cell-free fetal nucleic acids for noninvasive prenatal diagnostic RHD testing
Rather et al. Reappraisal of evolving methods in non-invasive prenatal screening: Discovery, biology and clinical utility
Fitzpatrick et al. Fine mapping and SNP analysis of positional candidates at the preeclampsia susceptibility locus (PREG1) on chromosome 2
Hammer et al. High positive predictive value 22q11. 2 microdeletion screening by prenatal cell‐free DNA testing that incorporates fetal fraction amplification
Gahan Circulating nucleic acids in plasma and serum: applications in diagnostic techniques for noninvasive prenatal diagnosis
Woon et al. Droplet digital PCR for identifying copy number variations in patients with primary immunodeficiency disorders
Keller Challenges with assigning RH alleles and accurately predicting phenotypes using commercially-available genotyping kits: a narrative review
Hizem et al. Polymorphisms in genes coding for the NK‐cell receptor NKG 2D and its ligand MICA in recurrent miscarriage
Daniels et al. Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin
Zacarias et al. Frequency of RHD variants in Brazilian blood donors from Parana State, Southern Brazil
US20200123615A1 (en) Monitoring method for adult t-cell leukemia/lymphoma (atl)
Weiss et al. KIR2DL4 genetic diversity in a Brazilian population sample: implications for transcription regulation and protein diversity in samples with different ancestry backgrounds